The FDA faces several challenges in toxicology, including the need to keep pace with scientific advancements and emerging toxicological threats. The agency must also balance the rapid approval of beneficial products with the thorough assessment of their safety. Additionally, the increasing complexity of substances and the need for alternative testing methods present ongoing challenges for the FDAâs toxicology efforts.
